Skip to main content

Csenge Advisory Group

SEC CIK
0001715593
Latest filing
Aug 10, 2026

MET holding history

Metlife Inc in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MET overviewAll 13F holders of METFull Q2 2026 holdings

Shares (Q2 2026)
9,559
Value
$808.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of MET by Csenge Advisory Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,559$808.8K<0.1%+28+0.3%AddedHolders
Q1 20269,531$674.0K<0.1%−325−3.3%ReducedHolders
Q4 20259,856$778.0K<0.1%−96−1.0%ReducedHolders
Q3 20259,952$819.8K<0.1%−2,416−19.5%ReducedHolders
Q2 202512,368$971.9K0.1%−1,279−9.4%ReducedHolders
Q1 202513,647$990.1K0.1%+131+1.0%AddedHolders
Q4 202413,516$1.11M0.1%+1,095+8.8%AddedHolders
Q3 202412,421$1.06M0.1%−336−2.6%ReducedHolders
Q2 202412,757$895.4K0.1%−296−2.3%ReducedHolders
Q1 202413,053$967.3K0.1%+374+2.9%AddedHolders
Q4 202312,679$838.4K0.1%+450+3.7%AddedHolders
Q3 202312,229$769.3K0.1%−1,687−12.1%ReducedHolders
Q2 202313,916$786.7K0.1%+845+6.5%AddedHolders
Q1 202313,071$757.3K0.1%−3,817−22.6%ReducedHolders
Q4 202216,888$1.22M0.1%+93+0.6%AddedHolders
Q3 202216,795$1.02M0.1%−1,442−7.9%ReducedHolders
Q2 202218,237$1.15M0.1%−130−0.7%ReducedHolders
Q1 202218,367$1.29M0.1%−2,370−11.4%ReducedHolders
Q4 202120,737$1.25M0.1%−188−0.9%ReducedHolders
Q3 202120,925$1.31M0.1%+188+0.9%AddedHolders
Q2 202120,737$1.25M0.1%+8,625+71.2%AddedHolders
Q1 202112,112$750.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.